R. Bekele

发表

Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance.

N. Samadi, G. Venkatraman, D. Brindley, 2011, Biochimie.

PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancer

Z. Szallasi, K. Mouw, A. Choudhury, 2022, npj Precision Oncology.

RAF1 amplification drives a subset of bladder tumors and confers sensitivity to MAPK-directed therapeutics.

E. V. Van Allen, G. Sonpavde, A. Thorner, 2021, The Journal of clinical investigation.

How can molecular abnormalities influence our clinical approach

M. Birrer, Rajesh Kumar, Wei Wei, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Identification of a Synthetic Lethal Relationship between Nucleotide Excision Repair Deficiency and Irofulven Sensitivity in Urothelial Cancer

Z. Szallasi, S. Brunak, I. Csabai, 2020, Clinical Cancer Research.

Role of autotaxin and lysophosphatidate in cancer progression and resistance to chemotherapy and radiotherapy

R. Bekele, S. David, 2012 .

How can molecular abnormalities influence our clinical approach.

M. Birrer, B. Wu, R. Bekele, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Oxidative stress contributes to the tamoxifen-induced killing of breast cancer cells: implications for tamoxifen therapy and resistance

J. Mackey, R. Godbout, Rong-Zong Liu, 2016, Scientific Reports.

Recent advances in targeting the autotaxin-lysophosphatidate-lipid phosphate phosphatase axis in vivo

G. Venkatraman, D. Brindley, M. Benesch, 2015, Journal of biomedical research.

Lysophosphatidate Induces Chemo-Resistance by Releasing Breast Cancer Cells from Taxol-Induced Mitotic Arrest

L. Schang, N. Samadi, I. Goping, 2011, PloS one.

ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer

J. Efstathiou, K. Mouw, K. Felt, 2023, Science advances.